 |
 |

Allergic Fungal Rhinosinusitis
Experience With Immunotherapy
Arch Otolaryngol Head Neck Surg. 1998;124:1178-1179.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
IN AUGUST 1994, when we began a prospective study to investigate the effect of IT with specific fungal antigens in patients with AFRS, it was our initial intention to prove or disprove their harmful effect in this situation. We have been gratified to find that far from exacerbating the course of this generally relentless and recalcitrant disease, fungal IT appears to significantly alter the clinical course of these patients, sparing them from repeated surgery and the use of systemic corticosteroids. Although our experience now exceeds 4 years and more than 20 patients treated in this fashion, we continue to believe that what we do not know about AFRS far exceeds our certain knowledge of the subject.
Figure appears in full text version.
|
|
|
|
Cynthia S. Mabry, RN, CORLN, and Richard L. Mabry, MD
|
|
|
We previously documented that patients with AFRS have high levels of total IgE as well as IgE-mediated atopy to multiple fungal and nonfungal antigens.1 . . . [Full Text of this Article]
RELATED ARTICLES
What Role Do Systemic Corticosteroids, Immunotherapy, and Antifungal Drugs Play in the Therapy of Allergic Fungal Rhinosinusitis?
Berrylin J. Ferguson
Arch Otolaryngol Head Neck Surg. 1998;124(10):1174-1178.
EXTRACT
| FULL TEXT
Allergic Fungal Rhinosinusitis: Our Experience
Frederick A. Kuhn and Amin R. Javer
Arch Otolaryngol Head Neck Surg. 1998;124(10):1179-1180.
EXTRACT
| FULL TEXT
|